A2M the a2 milk company limited

1.67%

$7.93

Ann: Deferral of FDA consideration of enforcement discretion, page-128

First 128 Last

Share
Profile

Follow
remirez

11,796 Posts.

565

10/08/22

18:35

Post #: 63039590
Share

Originally posted by CarlosG: ↑

Some highlights from nzherald:

"A2 Milk said the Food and Drug Administration (FDA) had deferred the company's request to send infant formula to the US but said approval would not have made a material difference to its results for the current financial year.

The FDA's communication did not go into why it had deferred a2 Milk's request but had approved requests from very minor players, such as Australia's Bubs.

Chief executive David Bortolussi said feedback from a2 Milk's US team was that the infant milk formula crisis had not been solved with significant retail out-of-stock issues continuing across the country.

"The a2 Milk Company stands ready to support US parents and caregivers during this critical time with approximately 1 million cans of premium a2 Platinum infant milk formula (27m 8oz bottle serves) through to the end of the November discretionary period and has one of the largest capacities in the industry to provide long term supply," Bortolussi said.

"In any event, we would not expect that this opportunity over the current FDA enforcement discretion period would have a material impact on the company's financial results in 2023 due to the market dynamics and cost to serve the US infant milk formula market," he said.

Dual-listed a2 Milk's main infant formula market is China, and analysts have long debated whether the ability to send some stock to the US would be a help or a hindrance for the former high flier, whose earnings have come under pressure in recent years.

While a2 Milk does not sell infant formula in the US, the company is making a big push there with its dairy products, which contain just the a2 beta protein and not the a1 beta protein that exists in standard milk.

In 2015 a2 Milk entered the US on a fresh milk platform, in much the same way as it had done in the Australian market, which later became a springboard for bigger and better things.

A2 Milk is firmly focused on China - the world's biggest infant formula market - where it has a significant presence despite a falling birth rate there."

Expand

If China invades Taiwan, what impact would that have on the formula market ? I see quite abit of commentary in the news about that being a possibility lately. I suppose the risk is already priced in at these levels ?

Last edited by remirez: 10/08/22

A2M Price at posting: $4.76 Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 128 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $7.93		Change 0.130(1.67%)		Mkt cap ! $5.741B

Open	High	Low	Value	Volume
$7.87	$7.99	$7.71	$17.74M	2.261M

Buyers (Bids)

No.	Vol.	Price($)
4	111	$7.93

Sellers (Offers)

Price($)	Vol.	No.
$7.96	3799	2

View Market Depth

No.	Vol.	Price($)
4	111	7.930
2	2969	7.910
1	5534	7.870
1	5534	7.860
1	5534	7.850

Price($)	Vol.	No.
7.960	565	1
7.970	5534	1
7.980	20346	2
7.990	19765	5
8.000	11947	9

Last trade - 16.13pm 27/06/2025 (20 minute delay)

A2M (ASX) Chart

Ann: Deferral of FDA consideration of enforcement discretion, page-128

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Deferral of FDA consideration of enforcement discretion, page-128

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News